Actelion Pharmaceuticals Ltd / Invitation: Actelion to discuss full year 2015 financial results . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Dear member of the investment community
Actelion Ltd will announce its 2015 full year financial results on Tuesday, 9 February 2016, at 07.00 hrs CET / 06.00 hrs GMT / 01.00 a.m. EST.
An investor conference call & webcast will be held at 14.00 hrs, CET to discuss the results.
To support your preparations, consensus estimates can be found under www.actelion.com/consensus-estimate
Date/Time:
9 February 2016 | 14.00 hrs - 14.45 hrs | Basel (CET) |
13.00 hrs - 13.45 hrs | UK (GMT) | |
8.00 a.m. - 8.45 a.m. | US (EST) |
Conference Call Connect #:
Dial-in participants should start calling the number below 10-15 minutes before the conference is due to start.
Dial: | Europe: | +41 (0)44 583 18 01 | |||
UK: | +44 (0)203 194 05 61 | ||||
US: | +1 646 722 48 98 | ||||
Participant's mode:
Listen-Only with possibility to open individual lines during Q&A session.
Participants will be asked for their Name and Company.
Webcast Access:
Webcast participants should visit the Actelion website http://www.actelion.com 10-15 minutes before the conference is due to start.
Participant's mode: Listen-Only
Webcast Replay:
The archived Investor Webcast will be available for replay through http://www.actelion.com/ approximately 60 minutes after the call has ended.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Globenewswire
--- End of Message ---
Actelion Pharmaceuticals Ltd
Gewerbestrasse 16 Allschwil Switzerland
ISIN: CH0010532478;